Interested in becoming a Radiesse^® Provider?

Radiesse Opt in Form For Physicians

"*" indicates required fields

Company

This field is for validation purposes and should be left unchanged.

About Your Practice

How did you learn about Radiesse (optional)

Practice Name*

Practice / Business Website*

Your Practice's Address*

Province

Area of Practice*

Does your practice have an MD?*

Your Name*

First Last

Position*

How Can We Reach You?

We would love to chat with you. How can we get in touch?

Preferred Method of Contact

Your Email Address*

Email Address Confirm Email Address

Your Phone*

Your Comments/Questions*

*By submitting this form, you agree to allow Merz Aesthetics Canada Ltd. to contact you and email you product news and information about RADIESSE® as well as selected news and information from Merz Aesthetics Canada Ltd. Please read our Terms of Use and Privacy Policy for more information.

RADIESSE^® and RADIESSE^® (+) are indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, and for the rejuvenation of the hand. RADIESSE^® injectable implant diluted 1:2 with 0.9% sterile saline for injections is intended for the treatment of moderate and severe décolleté wrinkles.

Warnings:

As with all dermal fillers, introduction of RADIESSE^® or RADIESSE^® (+) injectable implant into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction.
Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, and damage to underlying facial structures.
Immediately stop the injection if a patient exhibits any of the following symptoms, including changes in vision, signs of a stroke, blanching of the skin, or unusual pain during or shortly after the procedure.
Patients should receive prompt medical attention and possibly evaluation by an appropriate healthcare practitioner specialist should an intravascular injection occur.
Use of RADIESSE^® or RADIESSE^® (+) injectable implant in any person with active skin inflammation or infection in or near the treatment area should be deferred until the inflammatory or infectious process has been controlled.
Injection procedure reactions have been observed consisting mainly of short-term (i.e., <7 days) bruising, redness, swelling, lumpiness, pain, itching, discolouration, and tenderness.
Do not overcorrect (overfill) a contour deficiency because the depression should gradually improve within several weeks as the treatment effect of RADIESSE^® (+) injectable implant occurs. In extreme cases site rupture could occur with overcorrection.
Not intended for use in the breasts or for use in the lips.

Consult the Instructions for Use for a complete list of warnings, precautions, and other important safety information. The Instructions for Use are available by calling us at 1-866-815-8715 or found here.

Interested in becoming a Radiesse® Provider?

Radiesse Opt in Form For Physicians

About Your Practice

How Can We Reach You?

Interested in becoming a Radiesse^® Provider?